291 related articles for article (PubMed ID: 31712218)
1. Emergence of Ceftriaxone Resistance during a Case of Pneumococcal Meningitis with Fatal Evolution.
Mizrahi A; Marvaud JC; Pilmis B; Nguyen Van JC; Couzigou C; Bruel C; Engrand N; Le Monnier A; Lambert T
Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31712218
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of combined ceftriaxone and dexamethasone therapy in experimental cephalosporin-resistant pneumococcal meningitis.
Cabellos C; Martínez-Lacasa J; Tubau F; Fernández A; Viladrich PF; Liñares J; Gudiol F
J Antimicrob Chemother; 2000 Mar; 45(3):315-20. PubMed ID: 10702550
[TBL] [Abstract][Full Text] [Related]
3. Penicillin and ceftriaxone susceptibility of Streptococcus pneumoniae isolated from cerebrospinal fluid of children with meningitis hospitalized in a tertiary hospital in Israel.
Waisbourd-Zinman O; Bilavsky E; Tirosh N; Samra Z; Amir J
Isr Med Assoc J; 2010 Apr; 12(4):225-8. PubMed ID: 20803882
[TBL] [Abstract][Full Text] [Related]
4. Pharmacodynamics and bactericidal activity of ceftriaxone therapy in experimental cephalosporin-resistant pneumococcal meningitis.
Lutsar I; Ahmed A; Friedland IR; Trujillo M; Wubbel L; Olsen K; McCracken GH
Antimicrob Agents Chemother; 1997 Nov; 41(11):2414-7. PubMed ID: 9371342
[TBL] [Abstract][Full Text] [Related]
5. Nitric oxide concentrations and cerebrospinal fluid parameters in an experimental animal model of Streptococcus pneumoniae meningitis.
Destache CJ; Pakiz CB; Dash AK; Larsen C
Pharmacotherapy; 1998; 18(3):612-9. PubMed ID: 9620112
[TBL] [Abstract][Full Text] [Related]
6. Experimental study of teicoplanin, alone and in combination, in the therapy of cephalosporin-resistant pneumococcal meningitis.
Fernández A; Cabellos C; Tubau F; Maiques JM; Doménech A; Ribes S; Liñares J; Viladrich PF; Gudiol F
J Antimicrob Chemother; 2005 Jan; 55(1):78-83. PubMed ID: 15546968
[TBL] [Abstract][Full Text] [Related]
7. Three-year multicenter surveillance of pneumococcal meningitis in children: clinical characteristics, and outcome related to penicillin susceptibility and dexamethasone use.
Arditi M; Mason EO; Bradley JS; Tan TQ; Barson WJ; Schutze GE; Wald ER; Givner LB; Kim KS; Yogev R; Kaplan SL
Pediatrics; 1998 Nov; 102(5):1087-97. PubMed ID: 9794939
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the probability of target attainment between ceftriaxone and cefepime in the cerebrospinal fluid and serum against Streptococcus pneumoniae.
Lodise TP; Nau R; Kinzig M; Jones RN; Drusano GL; Sörgel F
Diagn Microbiol Infect Dis; 2007 Aug; 58(4):445-52. PubMed ID: 17512154
[TBL] [Abstract][Full Text] [Related]
9. Therapy of penicillin-resistant pneumococcal meningitis.
Schwartz MT; Tunkel AR
Zentralbl Bakteriol; 1995 Jan; 282(1):7-12. PubMed ID: 7734832
[TBL] [Abstract][Full Text] [Related]
10. Bacteriologic outcome of children with cefotaxime- or ceftriaxone-susceptible and -nonsusceptible Streptococcus pneumoniae meningitis.
Olivier C; Cohen R; Begué P; Floret D
Pediatr Infect Dis J; 2000 Oct; 19(10):1015-7. PubMed ID: 11055609
[No Abstract] [Full Text] [Related]
11. Evaluation of moxifloxacin, a new 8-methoxyquinolone, for treatment of meningitis caused by a penicillin-resistant pneumococcus in rabbits.
Ostergaard C; Sørensen TK; Knudsen JD; Frimodt-Møller N
Antimicrob Agents Chemother; 1998 Jul; 42(7):1706-12. PubMed ID: 9661008
[TBL] [Abstract][Full Text] [Related]
12. Dilemmas in diagnosis and management of cephalosporin-resistant Streptococcus pneumoniae meningitis.
Friedland IR; Shelton S; Paris M; Rinderknecht S; Ehrett S; Krisher K; McCracken GH
Pediatr Infect Dis J; 1993 Mar; 12(3):196-200. PubMed ID: 8451095
[TBL] [Abstract][Full Text] [Related]
13. Influence of dexamethasone on efficacy of ceftriaxone and vancomycin therapy in experimental pneumococcal meningitis.
Cabellos C; Martinez-Lacasa J; Martos A; Tubau F; Fernández A; Viladrich PF; Gudiol F
Antimicrob Agents Chemother; 1995 Sep; 39(9):2158-60. PubMed ID: 8540738
[TBL] [Abstract][Full Text] [Related]
14. Combined treatment with ceftriaxone and linezolid of pneumococcal meningitis: a case series including penicillin-resistant strains.
Faella F; Pagliano P; Fusco U; Attanasio V; Conte M
Clin Microbiol Infect; 2006 Apr; 12(4):391-4. PubMed ID: 16524418
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of fosfomycin alone and in combination with ceftriaxone or vancomycin in an experimental model of meningitis caused by two strains of cephalosporin-resistant Streptococcus pneumoniae.
Ribes S; Taberner F; Domenech A; Cabellos C; Tubau F; Liñares J; Viladrich PF; Gudiol F
J Antimicrob Chemother; 2006 May; 57(5):931-6. PubMed ID: 16507562
[TBL] [Abstract][Full Text] [Related]
16. In vitro killing of penicillin-susceptible, -intermediate, and -resistant strains of Streptococcus pneumoniae by cefotaxime, ceftriaxone, and ceftizoxime: a comparison of bactericidal and inhibitory activity with achievable CSF levels.
Stratton CW; Aldridge KE; Gelfand MS
Diagn Microbiol Infect Dis; 1995; 22(1-2):35-42. PubMed ID: 7587048
[TBL] [Abstract][Full Text] [Related]
17. Clinical outcome of pneumococcal meningitis during the emergence of pencillin-resistant Streptococcus pneumoniae: an observational study.
Gouveia EL; Reis JN; Flannery B; Cordeiro SM; Lima JB; Pinheiro RM; Salgado K; Mascarenhas AV; Carvalho MG; Beall BW; Reis MG; Ko AI
BMC Infect Dis; 2011 Nov; 11():323. PubMed ID: 22103652
[TBL] [Abstract][Full Text] [Related]
18. Treatment failure with use of a third-generation cephalosporin for penicillin-resistant pneumococcal meningitis: case report and review.
John CC
Clin Infect Dis; 1994 Feb; 18(2):188-93. PubMed ID: 8161625
[TBL] [Abstract][Full Text] [Related]
19. Mortality indicators in pneumococcal meningitis: therapeutic implications.
Erdem H; Elaldi N; Öztoprak N; Sengoz G; Ak O; Kaya S; Inan A; Nayman-Alpat S; Ulu-Kilic A; Pekok AU; Gunduz A; Gozel MG; Pehlivanoglu F; Yasar K; Yılmaz H; Hatipoglu M; Cicek-Senturk G; Akcam FZ; Inkaya AC; Kazak E; Sagmak-Tartar A; Tekin R; Ozturk-Engin D; Ersoy Y; Sipahi OR; Guven T; Tuncer-Ertem G; Alabay S; Akbulut A; Balkan II; Oncul O; Cetin B; Dayan S; Ersoz G; Karakas A; Ozgunes N; Sener A; Yesilkaya A; Erturk A; Gundes S; Karabay O; Sirmatel F; Tosun S; Turhan V; Yalci A; Akkoyunlu Y; Aydın E; Diktas H; Kose S; Ulcay A; Seyman D; Savasci U; Leblebicioglu H; Vahaboglu H
Int J Infect Dis; 2014 Feb; 19():13-9. PubMed ID: 24211227
[TBL] [Abstract][Full Text] [Related]
20. Vancomycin Should Be Part of Empiric Therapy for Suspected Bacterial Meningitis.
Olarte L
J Pediatric Infect Dis Soc; 2019 May; 8(2):187-188. PubMed ID: 30496558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
